Figure 2.
Summary of proteasome inhibitors, including the widely used probe compound MG132, as well as bortezomib/Velcade™ and carfilzomib/Kyprolis™, FDA approved drugs for the treatment of multiple myeloma.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.